Document is current
Any future updates will be listed below
-
Authors
Qu, Ning
Tong, Xiaochu
Wang, Zhaokun
Shao, Panpan
Zhang, Lehan
Zhang, Xiaoya
Xing, Yuxin
Liu, Jin
Wang, Yitian
Zhang, Sulin
Zheng, Mingyue
Li, Xutong
-
Funding
Funding for this research was provided by:
Shanghai Sailing Program (24YF2755600)
China Postdoctoral Science Foundation (2024M763421)
Strategic Priority Research Program of the Chinese Academy of sciences (XDB1260301)
Strategic Priority Research Program of the Chinese Academy of sciences (XDB0830000)
Youth Innovation Promotion Association CAS (2023296)
Research Funds of Hangzhou Institute for Advanced Study (2025HIAS-ZL007)
Research Funds of Hangzhou Institute for Advanced Study, UCAS (2025HIAS-ZL018)
Lingang Laboratory (LGL-8888)
Key Technologies R D Program of Guangdong Province (2023B1111030004)
Shanghai Municipal Science and Technology Major Project
Innovative Drug Research and Development — National Science and Technology Major Project (2025ZD1801200)
National Natural Science Foundation of China (82204278)
- License Information
-
More Information
Article History
Received: 7 September 2025
Accepted: 30 April 2026
First Online: 13 May 2026
Competing interests
: M.Z., X.L., N.Q., and X.T. are listed as inventors on a pending Chinese patent application related to the BioGDR framework described in this manuscript. The patent is filed by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The full list of inventors includes Mingyue Zheng, Xutong Li, Ning Qu, Xiaochu Tong, Xiangying Xie, Chen Zhang, and Mingyan Xu. The patent, entitled “Construction and application of a tumor drug sensitivity prediction model”, was filed on February 28, 2025, under application number CN202510234543.8, and is currently pending. The remaining authors declare no competing financial or non-financial interests.
